Home GSK, Prosensa muscular dystrophy drug misses study goal
 

Keywords :   


GSK, Prosensa muscular dystrophy drug misses study goal

2013-09-20 17:19:30| Biotech - Topix.net

An experimental drug for Duchenne muscular dystrophy from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stage clinical trial, sending shares in Prosensa tumbling 75 percent in pre-market trade.

Tags: study goal drug muscular

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »